REVALESIO ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 RESCUE STUDY OF RNS60 IN PATIENTS WITH ACUTE ISCHEMIC STROKE IN LATE-BREAKING ORAL PRESENTATION AT ISC 2024

RNS60 met its primary endpoints in RESCUE (safety and mortality) Clinically relevant improvement with RNS60 on modified Rankin Scale (mRS), Barthel Index and National Institute of Health Stroke Scale (NIHSS) Significant lowering of infarct growth by 50% at 48 hours Revalesio plans to meet…